X0508 4 2023-07-19 0001275187 ANGIODYNAMICS INC ANGO 0001706852 Campbell Chad Thomas 14 PLAZA DRIVE LATHAM NY 12110 true SVP/GM, Vascular Access false Common Stock 2023-07-19 4 A 0 11384 0 A 48263 D Performance Right 2023-07-19 4 A 0 22768 0 A Common Stock 22768 22768 D Non-Qualified Stock Option (right to buy) 8.92 2023-07-19 4 A 0 23561 0 A 2024-07-19 2033-07-19 Common Stock 23561 23561 D The acquisition of 11,384 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 11,384 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 19, 2024, such that 25% of the restricted stock units will vest on each of July 19, 2024, 2025, 2026 and 2027. Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited. These stock options vest in four equal annual installments beginning on July 19, 2024, such that 25% of the options will vest on each of July 19, 2024, 2025, 2026 and 2027. /s/ Stephen A. Trowbridge, Attorney in Fact 2023-07-21